Área de Investigación en Vacunas, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
RSV Medical Evidence Generation, Sanofi Pasteur, Lyon, France.
Influenza Other Respir Viruses. 2022 Mar;16(2):328-339. doi: 10.1111/irv.12937. Epub 2021 Nov 24.
RSV is the leading cause of hospital admissions in infants and the principal cause of bronchiolitis in young children. There is a lack of granular data on RSV-associated hospitalization per season using laboratory confirmed results. Our current study addresses this issue and intends to fill this gap.
The study was conducted from 2014 through 2018, in 4 to 10 hospitals in the Valencia Region, Spain. Infants included in this study were admitted in hospital through the Emergency Department with a respiratory complaint and tested by RT-PCR for RSV in a central laboratory.
Incidence rates of RSV-associated hospitalization varied by season and hospital. Overall, the highest incidence rates were observed in 2017/2018. RSV-associated hospitalization was highest in infants below 3 months of age and in those born before or at the beginning of the RSV season. Almost 54% of total infants hospitalized with laboratory confirmed RSV were found to be born outside the season, from April to October. The RSV positivity rate by ICD-10 discharged codes varied by season and age with results from 48% to 57% among LRI (J09-J22).
The study was instrumental in bringing forth the time unpredictability of RSV epidemics, the critical impact of age, and the comparable distribution of RSV-associated hospitalization in infants born on either side of the RSV season. These data could help in better characterization of the population that drives the healthcare burden and is crucial for the development of future immunization strategies, especially with upcoming vaccines in against RSV.
RSV 是婴儿住院的主要原因,也是幼儿毛细支气管炎的主要原因。缺乏使用实验室确诊结果按季节划分的与 RSV 相关的住院的详细数据。我们目前的研究解决了这个问题,并旨在填补这一空白。
该研究于 2014 年至 2018 年在西班牙瓦伦西亚地区的 4 到 10 家医院进行。本研究纳入的婴儿通过急诊因呼吸道症状住院,并在中央实验室通过 RT-PCR 检测 RSV。
与 RSV 相关的住院率因季节和医院而异。总体而言,2017/2018 年观察到的发病率最高。3 个月以下的婴儿和 RSV 季节前或早期出生的婴儿与 RSV 相关的住院率最高。几乎 54%的因实验室确诊 RSV 住院的婴儿被发现出生于季节之外,即 4 月至 10 月。按 ICD-10 出院代码分类的 RSV 阳性率因季节和年龄而异,LRI(J09-J22)的结果为 48%至 57%。
该研究揭示了 RSV 流行的时间不可预测性、年龄的关键影响以及 RSV 相关住院在 RSV 季节前后出生的婴儿中的分布相当。这些数据有助于更好地描述导致医疗负担的人群,对于制定未来的免疫策略至关重要,特别是针对即将推出的 RSV 疫苗。